Sativex (cannabis-derived) Trial Planned For Alzheimer’s

UK researchers are launching a trial looking at a cannabis-based therapy for Alzheimer’s

https://www.marketwatch.com/story/uk-researchers-are-launching-a-phase-2-trial-looking-at-a-cannabis-based-therapy-for-alzheimers-2019-02-15

The study team plans to recruit volunteers between 55 and 90 years of age who have symptoms of agitation or aggression. The volunteers will be split into two groups: those who receive Sativex and those who receive a placebo. After four weeks, researchers will evaluate the results.